Table 2.

Clinical course of patients in the study and control groups

	Study group	Control group	P
Median duration of hospital stay ± (range)	10 ± 4 (8-14)	15 ± 6 (7-26)	< 0.05
Median value of days in ICU ± (range)	6 ± 2 (5-8)	6 ± 2 (5-7)	NS
Median duration of EN ± (range)	8 ± 4 (6-12)	10 ± 4 (6-13)	NS
Median duration (days) of serum amylase or lipase normalization ± (range)	7 ± 2 (6-9)	8 ± 3 (6-11)	NS
Complications
Multiorgan failure (n)	1	2
Cholangitis (n)	1	0
Sepsis (n)	1	2
Pseudocyst (n)	2	1
Number of deaths (n)	2	4
Overall complications (%)	7/15 (46.6)	9/15 (60%)	< 0.05

ICU: intensive care unit; EN: enteral nutrition; NS: not significant.